The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies to open Occluded arteries (GUSTO) V trial

American Heart Journal

Volumn 150, Issue 1, 2005, Pages 89-93

  Brener, Sorin J ^a,i   Lincoff, A Michael ^a   Bates, Eric R ^b   Jia, Gang ^a   Armstrong, Paul W ^c   Guetta, Victor ^d   Hochman, Judith S ^e   Savonitto, Stefano ^f   Wilcox, Robert G ^g   White, Harvey D ^h   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d SHEBA MEDICAL CENTER   (Israel)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 23244435032     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.030     Document Type: Article

References (14)

1. E. Boersma, A.C. Maas, and J.W. Deckers Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour Lancet 348 1996 771 775
2. The ASSENT 2 Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators Lancet 354 1999 716 722
3. The GUSTO III Investigators A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators N Engl J Med 337 1997 1118 1123
4. E.J. Topol Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 2001 1905 1914
5. A.M. Lincoff, R.M. Califf, and F. Van De Werf Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial JAMA 288 2002 2130 2135
6. S. Savonitto, P.W. Armstrong, and A.M. Lincoff Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial Eur Heart J 24 2003 1807 1814
7. The In TIME Investigators Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction Eur Heart J 21 2000 2005 2013
8. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
9. D.A. Morrow, E.M. Antman, and L. Parsons Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA 286 2001 1356 1359
10. K.L. Lee, L.H. Woodlief, and E.J. Topol Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
11. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation 110 2004 588 636
12. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
13. E.M. Antman Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial Circulation 94 1996 911 921
14. E.M. Antman Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial Circulation 90 1994 1624 1630